BARDA’s Onshoring of Viral Hemorrhagic Fevers Vaccine Candidates
As the global health landscape evolves, so too must the United States’ ability to respond rapidly to biological threats. To strengthen its readiness posture, the Biomedical Advanced Research and Development Authority (BARDA), in coordination with the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the BioMaP Consortium OT Vehicle. This
BARDA’s Onshoring of Viral Hemorrhagic Fevers Vaccine Candidates Read More »